Penn State University campus. (Rob Carr/Getty Images)
Scientists from the Pennsylvania State University have developed a new treatment that allegedly reduces COVID-infections by 95 percent in 12 hours. According to Penn State News, the new treatment uses a deficient version of COVID-19 that destroys the actual virus in infected patients.
Led by Eberly's Marco Archetti, a @penn_state research team has designed a new COVID-19 therapy that uses a defective version of the SARS-CoV-2 virus to drive the disease-causing version to extinction. https://t.co/Hyo3Ft8k2P @BMB_PSU @PennStateBio @huckinstitutes @joselab_psu pic.twitter.com/nHUuizPQvN
— Penn State Eberly College of Science (@PSUScience) July 10, 2021
The scientists said they created the defective interfering virus in a lab, stating it replicates three times faster than the actual COVID-19 strain and suppresses the infection. However, they added that further experiments are still needed before it can be promoted as an antiviral treatment.
As a result, the actual COVID-19 virus becomes unable to reproduce and dies out under pressure by the immune system. The new treatment is slated to be available as a one-time inoculation of COVID-infected patients.
Source: One America News Network
